Investing Profile

Lars Ekman

InvestorVC
Excecutive Partner at Sofinnova Investments
Photo of Lars Ekman, Sofinnova Investments

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
cb
$100K - $5.0M
$1.5M
3
CompanyStageDateRound SizeTotal Raised
Cebix
Series BOct 2012$33M
Series UnknownSep 2010$16M
Series AOct 2008$3M
$52M
Co-investors: Nina Kjellson (Canaan Partners)
Vice President of Research and Development HotmailPresent
EVP, Research and Development Pharmacia GmbHPresent
President R&D Schwarz PharmaPresent
EVP, President of Research & Development Elan PharmaceuticalsPresent
Excecutive Partner Sofinnova InvestmentsPresent
University of Gothenburg MD PhD, Medicine and Molecular Biology
University of Gothenburg MD, PhD Medicine and Molecular Biology